scispace - formally typeset
A

Anne E. Sales

Researcher at University of Michigan

Publications -  230
Citations -  7844

Anne E. Sales is an academic researcher from University of Michigan. The author has contributed to research in topics: Health care & Veterans Affairs. The author has an hindex of 44, co-authored 219 publications receiving 6771 citations. Previous affiliations of Anne E. Sales include Veterans Health Administration & United States Department of Veterans Affairs.

Papers
More filters
Journal ArticleDOI

Organizational readiness to change assessment (ORCA): development of an instrument based on the Promoting Action on Research in Health Services (PARIHS) framework.

TL;DR: An Organizational Readiness to Change Assessment instrument (ORCA), organized according to the core elements and sub-elements of the PARIHS framework, is introduced and general support for the reliability and factor structure is found.
Journal ArticleDOI

Pre-pregnancy body mass index, gestational weight gain, and other maternal characteristics in relation to infant birth weight

TL;DR: Findings support the need to balance pre-pregnancy weight and gestational weight gain against the risk of LBW and macrosomia among lean and obese women, respectively.
Journal ArticleDOI

Practice Feedback Interventions: 15 Suggestions for Optimizing Effectiveness

TL;DR: 15 suggestions that are likely to improve the effectiveness of feedback across a range of contexts are identified and underutilized in the literature, given that their specific mechanisms of effectiveness have seldom been explored in detail.
Journal ArticleDOI

No more 'business as usual' with audit and feedback interventions: towards an agenda for a reinvigorated intervention.

TL;DR: It is argued that continuing the ‘business as usual’ approach to evaluating two-arm trials of audit and feedback interventions against usual care for common problems and settings is unlikely to contribute new generalizable findings.
Journal ArticleDOI

Effectiveness of Statin Therapy in Adults With Coronary Heart Disease

TL;DR: Statin therapy reduces mortality and morbidity in adults with CHD, even at pretreatment LDL-C levels as low as 100 mg/dL (2.59 mmol/L), and meta-regression analyses revealed risk reductions for CHD mortality or nonfatal myocardial infarction and major vascular events across available pretreatment cholesterol levels.